Charles Rhyee

TD Cowen | Healthcare

Charles Rhyee is an analyst from TD Cowen specializing in the Healthcare sector. Ranked #1579 out of 4771 analysts, they have issued 43 stock ratings with a success rate of 88.22% and an average return of 17.76%.

Charles Rhyee has a well-established track record, with 43 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 88.22% and an average return of 17.76%, underscoring their expertise and ability to identify winning opportunities for investors.

#1579

Out of 4771

43

Total Ratings

+88.22%

Success Rate

+17.76%

Average Return

Recent Ratings Analysis

FTRE

Aug 04, 2026

Target

$23.00

Current

$17.02

Performance

-5.39%

Charles Rhyee rated FTRE as Buy on Aug 04, 2026, setting a price target of 23. The stock has underperformed, dropping 5.39% despite the bullish target of 23.

IQV

Jul 29, 2026

Target

$288.00

Current

$257.30

Performance

3.93%

On Jul 29, 2026, IQV was given a Buy rating by Charles Rhyee, with a target price of 288. The stock traded sideways with a 3.93% move, keeping the bullish thesis unresolved.

EVH

Jul 28, 2026

Target

$5.00

Current

$4.17

Performance

11.50%

EVH received a Buy rating from Charles Rhyee on Jul 28, 2026, aiming for 5. Momentum has favored the Buy call, with shares climbing from 4.17 to 4.17, rewarding those who trusted the recommendation.

MEDP

Jul 24, 2026

Target

$492.00

Current

$583.16

Performance

-3.03%

On Jul 24, 2026, Charles Rhyee published a Hold outlook on MEDP, with a target of 492. Sideways action left the Hold view intact, with no major move since 583.16.

MCK

Jul 21, 2026

Target

$989.00

Current

$880.86

Performance

6.28%

Charles Rhyee on Jul 21, 2026 assigned MCK a Buy rating, with a price target of 989. The Buy call aligned well with market performance, producing a gain of 6.28%.

CAH

Jul 09, 2026

Target

$275.00

Current

$236.02

Performance

0.96%

On Jul 09, 2026, Charles Rhyee reaffirmed CAH with a Buy rating, targeting 275. Market indecision has kept the 275 target in a holding pattern.

ICLR

Jun 25, 2026

Target

$197.00

Current

$165.69

Performance

2.94%

ICLR was rated Buy by Charles Rhyee on Jun 25, 2026, with a price objective of 197. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

BTSG

Jun 18, 2026

Target

$81.00

Current

$57.88

Performance

-12.63%

On Jun 18, 2026, Charles Rhyee initiated coverage on BTSG with a Buy rating and target of 81. The Buy call has yet to be validated as shares remain 23.12 away from the target.

DRIO

May 13, 2026

Target

$11.00

Current

$6.58

Performance

-18.77%

Charles Rhyee issued a Hold recommendation for DRIO on May 13, 2026, price target set at 11. Market action validated the conservative Hold outlook with shares at 6.58.

GDRX

May 11, 2026

Target

$4.00

Current

$3.35

Performance

17.96%

On May 11, 2026, GDRX was evaluated by Charles Rhyee, who gave a Buy rating and target of 4. This case illustrates how a timely bullish rating can translate into tangible gains of 17.96%.

CVS

May 11, 2026

Target

$110.00

Current

$95.29

Performance

3.33%

Charles Rhyee rated CVS as Buy on May 11, 2026, setting a price target of 110. Shares have remained stable near 95.29, leaving the 110 target still in play.

AMWL

May 06, 2026

Target

$8.00

Current

$12.79

Performance

78.88%

On May 06, 2026, AMWL was given a Hold rating by Charles Rhyee, with a target price of 8. The stock rallied from 12.79 to 12.79 after the Hold rating, surprising to the upside.

OPCH

May 01, 2026

Target

$23.00

Current

$23.63

Performance

—

OPCH received a Hold rating from Charles Rhyee on May 01, 2026, aiming for 23. Shares remained flat at 23.63, aligning with the neutral rating.

VEEV

Mar 05, 2026

Target

$380.00

Current

$260.98

Performance

—

On Mar 05, 2026, Charles Rhyee published a Buy outlook on VEEV, with a target of 380. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 260.98.

TDOC

Feb 26, 2026

Target

$8.00

Current

$6.09

Performance

13.83%

Charles Rhyee on Feb 26, 2026 assigned TDOC a Hold rating, with a price target of 8. Shares outperformed expectations, climbing 13.83% despite the neutral view.

TALK

Feb 20, 2026

Target

$9.00

Current

$5.25

Performance

5.21%

On Feb 20, 2026, Charles Rhyee reaffirmed TALK with a Buy rating, targeting 9. The recommendation was supported by strong follow-through as the stock rose from 5.25 to 5.25.

CRL

Feb 20, 2026

Target

$251.00

Current

$273.00

Performance

61.61%

CRL was rated Buy by Charles Rhyee on Feb 20, 2026, with a price objective of 251. A bullish response from the market helped close the gap of -22.00 to the target.

CI

Feb 09, 2026

Target

$338.00

Current

$280.91

Performance

-4.58%

On Feb 09, 2026, Charles Rhyee initiated coverage on CI with a Buy rating and target of 338. Neutral price movement of -4.58% leaves room for interpretation.

MDLN

Jan 12, 2026

Target

$46.00

Current

$32.39

Performance

-24.18%

Charles Rhyee issued a Buy recommendation for MDLN on Jan 12, 2026, price target set at 46. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

COR

Nov 10, 2025

Target

$400.00

Current

$320.95

Performance

-11.98%

On Nov 10, 2025, COR was evaluated by Charles Rhyee, who gave a Buy rating and target of 400. Investors saw limited payoff as shares fell short of the 400 target.

Frequency Asked Questions

Who is Charles Rhyee?

Charles Rhyee is an analyst from TD Cowen specializing in the Healthcare sector.

What is Charles Rhyee's success rate?

Charles Rhyee currently has a success rate of +88.22%.

How many ratings has Charles Rhyee issued?

Charles Rhyee has issued 43 stock ratings so far.

What is the average return of Charles Rhyee's calls?

Their stock ratings have generated an average return of +17.76%.

What is Charles Rhyee's ranking?

Charles Rhyee is ranked #1579 out of 4771 analysts.

What types of ratings does Charles Rhyee give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Charles Rhyee?

You can follow Charles Rhyee by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Charles Rhyee?

Their latest rating was a Buy on FTRE issued on 2026-08-04.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep